Sector portfolio · Corporate investor · United States

SR One's Biotech portfolio

SR One has backed 44 Biotech startups in rounds we track, $5.6B between them, shown by the stage each has reached. The best-funded is Turning Point Therapeutics.

44startups backed
4stages
$5.6Braised between them
Series C and laterbiggest stage

SR One's whole portfolioSR One's profile

Series C and later

12

Series A

11

Series B

11

Stage not reported

10

Segment by segment

Series C and later

12 startups · $1.6B raised

  1. CORXEL PharmaceuticalsCORXEL Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2019, previously known as JiXing Pharmaceuticals.United States$287M
  2. Odyssey TherapeuticsOdyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.United States$238M
  3. Spero TherapeuticsSpero Therapeutics develops therapeutics for treatment of gram-negative infections.United States$199M
  4. Decibel TherapeuticsDecibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.United States$189M
  5. HotSpot TherapeuticsHotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.United States$145M
  6. TTTP TherapeuticsUnited States$126M
  7. PulmocidePulmocide is a private biopharmaceutical company based in London, United Kingdom, founded in 2007.United Kingdom$110M
  8. FORE BiotherapeuticsFore Biotherapeutics is a clinical-stage precision oncology company based in Philadelphia, PA.United States$108M

Series A

11 startups · $1.1B raised

  1. Morphic TherapeuticMorphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.United States$328M
  2. AirNexis TherapeuticsAirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.United States$200M
  3. Addition TherapeuticsAddition Therapeutics develops RNA-only therapeutics using PRINT technology for genetic medicine.United States$100M
  4. IImmutrinImmutrin is a biotech developing next‐generation antibody therapies to clear amyloid deposits and reverse amyloidosis.United Kingdom$87M
  5. Antag TherapeuticsAntag Therapeutics is a clinical-stage biopharmaceutical company based in Copenhagen, focused on developing innovative therapies fDenmark$84M
  6. Akamis BioAkamis Bio is a clinical-stage oncology company based in Cambridge, Massachusetts, dedicated to improving treatment for colorectalUnited Kingdom$60M
  7. Ancora BiotechAncora Biotech is a California-based biotechnology company that researches and develops T-cell therapies for the treatment of cancUnited States$60M
  8. GGothamUnited States$54M

Series B

11 startups · $1.3B raised

  1. Windward BioWindward Bio is a clinical-stage biotechnology company with deep discovery, development, and commercialization expertise committedSwitzerland$365M
  2. ArcellxArcellx is a clinical-stage biotechnology company focused on developing innovative immunotherapies for cancer and other incurable diseases.United States$285M
  3. MiroBioMiroBio is Harnessing the natural control mechanisms of the immune system.United Kingdom$144M
  4. Bicycle TherapeuticsBicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.United Kingdom$110M
  5. Palleon PharmaceuticalsPalleon Pharmaceuticals is a clinical-stage biotechnology company based in Waltham, Massachusetts.United States$100M
  6. Nimbus TherapeuticsNimbus Therapeutics is a clinical-stage biotechnology company based in Boston, Massachusetts, founded in 2009.United States$72M
  7. Avenzo TherapeuticsDeveloping the next generation of oncology therapies for patients.United States$60M
  8. NNucleonicsNucleonics is a biotechnology company focused on RNA interference-based therapeutics.United States$49M

Stage not reported

10 startups · $1.7B raised

  1. TPTurning Point TherapeuticsTurning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.-$460M
  2. Dren BioDren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.United States$375M
  3. AlumisAlumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.United States$345M
  4. True North TherapeuticsTrue North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases.United States$142M
  5. MISSION TherapeuticsMission Therapeutics is a clinical-stage biopharmaceutical company based in Cambridge, UK, focused on drug discovery and developmeUnited Kingdom$113M
  6. Principia BioPharmaPrincipia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.United States$90M
  7. NPNeuroTherapeutics PharmaNeuroTherapeutics Pharma is a biopharmaceutical company developing new therapies to treat pain, epilepsy, and other nervous system disorder.United States$58M
  8. ATAltiris TherapeuticsAltiris Therapeutics develops and commercializes drugs to treat metastatic cancer.United States$44M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names SR One as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Co-investorsWho invests with SR One63 co-investorsPortfolio mapSR One portfolio map59 startups · $8.3BSector portfolioCoinbase Ventures' Web3 & Crypto portfolio168 startups · $5.7BSector portfolioSalesforce Ventures' AI portfolio115 startups · $181BSector portfolioGoogle Ventures' AI portfolio81 startups · $16BSector portfolioGoogle Ventures' Biotech portfolio74 startups · $12B

Raising from investors like SR One?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps